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1. Introduction 
Chloroprothixene, a thioxanthene d rivative, 
significantly prolongs ethanol action [ 1 ]. Strong 
inhibitory activity of a series of phenothiazines on
Na, K-ATPase and horse liver alcohol dehydrogenase 
has been reported [2,3]. Chloropromazine and 
imipramine were also found to activate swine renal 
15-hydroxyprostaglandin dehydrogenase [4]. 
Glycogen phosphorylase b (EC 2.4.1.1) shows an 
absolute requirement for AMP for enzymatic action 
[5]. It has been shown that AMP activation is
enhanced by a variety of factors, e.g., substrate and 
buffer ions, anions, divalent metal ions and polyvalent 
organic ations [6-11 ]. 
In the present paper, we have studied the effect of 
a series of phenothiazine d rivatives (all being pharma- 
cologlcaUy active) upon the catalytic and structural 
properties of phosphorylase b. Our results indicate 
that some phenothiazines cause a significant enhance- 
ment of the binding of AMP to the enzyme. 
2. Materials and methods 
Phosphorylase b was isolated from rabbit skeletal 
muscles as in [12]. 2-Mercaptoethanol was used 
instead of L-cysteine in all steps of the isolation 
procedure. The enzyme was recrystallized four times 
and AMP was removed by passage through acolumn 
of Sephadex G-25. The enzyme concentration was 
measured spectroscopically using an extinction co- 
efficient (El%on) at 280 nm of 13.2 [13]. Activity 
assays of phosphorylase b were carried out in the 
direction of glycogen synthesis [14]. Inorganic phos- 
phate released in the reaction was measured as in 
[ 15]. No interference ofphenothiazines, when tested 
at various concentrations, during colorimetric deter- 
mination of phosphate was found [16]. Ultracentri- 
fugation studies were performed on a MSE Centriscan 
75, at a rotor speed of 60 000 rev/min and temp. 20°C. 
The enzyme concentration in all runs was 10 mg/ml. 
In all experiments, a 4 × 10 -2 M sodium/3-glycero- 
phosphate, 3 × 10 -2 M 2-mercaptoethanol and 
1 X 10 -a M EDTA buffer (pH 6.8) was used. 
Promazine.HC1 and chloropromazine.HC1 were 
obtained from two sources: Smith, Kline and French 
Laboratories (Philadelphia, PA) and MS Chemicals 
(Milano, Italy). These two compounds were pure by 
thin-layer chromatography (ammonium hydroxide/ 
benzene/dioxan, 5:60:35) [17]. Oyster glycogen, 
glycerophosphate nd EDTA were purchased from 
BDH. Glucose-l-phosphate nd AMP were products 
of Sigma. All other compounds and reagents were of 
the highest commercially available purity. 
3. Results 
The effect of increasing concentrations of 
promazine on the activity of phosphorylase b at 
various AMP concentrations is hown in fig.1. It can 
be seen that promazine stimulates AMP activation at 
various concentrations of the enzyme activator. 
Maximal activation at all AMP concentrations tested 
is attained at 4 × 10 -3 M promazine. Promazine is
most effective at lower AMP concentrations. After 
increasing promazine concentration above 4 X 10-3 M, 
stimulation of phosphorylase b activation by AMP 
is decreased. In all cases, however, maximum velocity 
of the enzyme is not affected by promazine. 
The sigmoid response of the enzyme to AMP is 
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Fig. 1. Effect of promazine on the activity of phosphorylase b. 
The enzyme (10 pg/ml) was assayed at 30°C with 1.6 X 10 -~ M 
glucose-I-phosphate, 1% glycogen and various concentrations 
of AMP and promazine mentioned in the figure. The enzyme 
activities without promazine were taken as 100%. 
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Fig.2. Lineweaver-Burk plots for AMP activation of phos- 
phorylase b, in the presence of 2, 5, 10, 20 and 40 X 10 -4 M 
promazine. Activities were expressed aspmol phosphate 
released/min/mg enzyme. The enzyme was assayed as in fig.1. 
partially affected by increasing of promazine con- 
centration i  the assay system, as shown in the 
Lineweaver-Burk plots for AMP binding to phos- 
phorylase b of fig.2. The Hill coefficient (n) and 
the K m value for this nucleotide are also dependent 
on the promazine concentration (table 1). In contrast 
to its effect on K m value for AMP, promazine has no 
effect on the affinity of the enzyme for the substrate, 
glucose-l-phosphate. At 1 × 10 -3 M AMP and 1% 
glycogen, the presence of 4 X 10 -3 M promazine does 
not affect the K m value for glucose-l-phosphate 
(7.9 X 10 -a M). 
Ultracentrifugation studies were performed to 
determine whether the dimer-tetramer quilibrium 
in phosphorylase b is affected by promazine. The 
following results were obtained: 
(i) The enzyme in the presence of 5 X 10 -4 M AMP 
has a sedimentation coefficient of 9.5 S, which 
corresponds mainly to the dimeric species [18]. 
(ii) In the presence of 2 X 10 -3 M promazine and 
5 X 10 -4 M AMP the sedimentation pattern 
shows two peaks, one of 10.4 S (11.5%) and 
another of 12.4 S (88.5%) which correspond to 
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an almost complete conversion of the enzyme to 
the tetrameric form. In contrast, promazine alone 
causes no alteration in the ultracentrifugal profile 
of phosphorylase b. A sedimentation coefficient 
of 8.4 S was found in the presence or absence of 
promazine (2 X 10 -3 M) in agreement with [19]. 
In order to detect structural requirements for the 
Table 1 
Effect of promazine on Hill coefficient (n) and K m value for 
AMP binding to phosphorylase b 
Ipromazine I K m n 
(M X 103) (M X l0 s) 
0 7.2 1.50 
2 6.3 1.40 
5 5.6 1.35 
10 4.5 1.40 
20 3.7 1.20 
40 2.6 1.15 
50 2.8 1.35 
60 6.5 1.35 
Affinity and interaction parameters were calculated as in [ 20] 
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Table 2 
Effect of structural analogues of promazine to phosphorylase b activity 
Structure 
1 
CH 2 -R2 
Promazine Rt=-H; R2=-CH2CH2-N(CH3) 2 204 
% Activation 
April 1978 
Chloropromazine R 1 =-CI; R2=-CH2CH2-N(CHs )2 191 
Promethazine R~ =-H; R2 =-CH(CH 3 )-N(CH~ )2 76 
Perazine RI=-H; R2=-CH2CHa-N N-CH 3 106 / 
Trifluoperazine R t =-CF 3 ; R2=-CH2CH 2-O-CH3 94 
Thioridazine R a =-SCHa ;R2=- CH 2 -~N~ 102 
1 
CH3 
Perphenazine R 1 =-CI, R~----CH~ CH 2 N N-CH2CH2OH 100 
X.._/ 
/ "X  
Fluphenazine RI=-CF 3 ; R2=-CH2CH 2-N N-CH2CH2OH 105 
X_./ 
The enzyme (10 ug/ml) was assayed with 1.6 X 10 -2 M glucose-l-phosphate, 1%glycogen, 
2 x 10 -s M AMP and 2 × 10 -3 M of each analogue. The enzyme activity without he analogue 
was taken as 100% 
mechanism of promazine action, a series ofpromazine 
analogues were tested in experiments similar to those 
utilized for demonstrating stimulation of  AMP acti- 
vation by promazine (table 2). 
4. Discussion 
Promazine nhances the binding of AMP to 
glycogen phosphorylase b as judged by the kinetic 
experiments and the formation of the tetrameric 
species jointly with the nucleotide (fig.l, table 1). 
This stimulation of AMP binding to the enzyme is 
possibly due to an interaction of the negatively- 
charged groups of  the protein molecule with the 
cationic group of the side-chain of the drug. In fact, 
such electrostatic interactions between phenothiazines 
and bovine serum albumin or bile salts have been 
reported [21,22]. As can be seen from the effects of 
various analogues of promazine upon the activity of 
phosphorylase b (table 2), the nature of the side- 
chain plays an important role for stimulation of 
enzyme activity. Besides the side-chain contribution, 
the observed phosphorylase b activation could have 
arisen also from a hydrophobic interaction between 
the apolar three ring system of the promazine mole- 
cule with a hydrophobic area of the enzyme molecule. 
315 
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